Get started
Author

Han Jo Kim

Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer
2016 · Sang Byung Bae, Hyun Deuk Cho, et al. · Journal of Breast Cancer · 98
PDF
Safety and Effectiveness of Central Venous Catheterization in Patients with Cancer: Prospective Observational Study
2010 · Hyun Jung Kim, Jina Yun, et al. · Journal of Korean Medical Science · 73
PDF
RhoA is associated with invasion and poor prognosis in colorectal cancer
2015 · DONGJUN JEONG, SOYOUNG PARK, et al. · International Journal of Oncology · 65
PDF
Pathophysiological Role of Hormones and Cytokines in Cancer Cachexia
2012 · Hyun Jung Kim, Han Jo Kim, et al. · Journal of Korean Medical Science · 54
PDF
Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases
2011 · Ji Yeon Kwon, Jina Yun, et al. · Cancer Research and Treatment · 53
High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer
2016 · Si-Hyong Jang, Jong Eun Lee, et al. · Journal of Breast Cancer · 48
PDF
Loss of Tumor Suppressor ARID1A Protein Expression Correlates with Poor Prognosis in Patients with Primary Breast Cancer
2015 · Hyun Deuk Cho, Jong Eun Lee, et al. · Journal of Breast Cancer · 44
PDF
Protein kinase, membrane‑associated tyrosine/threonine�1 is associated with the progression of colorectal cancer
2018 · Dongjun Jeong, Hyeongjoo Kim, et al. · Oncology Reports · 36
PDF
A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study
2015 · Hye Sook Han, Ji Chan Park, et al. · The Oncologist · 36
PDF
Prognostic Relevance of HJURP Expression in Patients with Surgically Resected Colorectal Cancer
2020 · Dong Hyun Kang, Jongsoo Woo, et al. · International Journal of Molecular Sciences · 35
PDF
Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer
2017 · Myung Jin Ban, Sang Hee Ji, et al. · Journal of Cancer Research and Clinical Oncology · 30
Attenuated FOLFIRINOX in the salvage treatment of gemcitabine‐refractory advanced pancreatic cancer: a phase II study
2018 · Jung Hoon Kim, Sang‐Cheol Lee, et al. · 癌症：英文版 · 26
PDF
Defensin alpha 6 (DEFA6) is a prognostic marker in colorectal cancer
2019 · Dongjun Jeong, Hyeongjoo Kim, et al. · Cancer Biomarkers · 23
PDF
MYH9 nephropathy
2014 · Taehoon Oh, Hyun Jung Seo, et al. · Kidney Research and Clinical Practice · 23
PDF
The BRAF mutation is associated with the prognosis in colorectal cancer
2014 · Tae Sung Ahn, Dongjun Jeong, et al. · Journal of Cancer Research and Clinical Oncology · 23
Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab
2014 · Jee Wan Wee, Young Woo Jeon, et al. · Blood Research · 20
PDF
Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer
2017 · Dongjun Jeong, Hyeongjoo Kim, et al. · Journal of Cancer Research and Clinical Oncology · 19
A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746).
2019 · Yeon Hee Park, Tae Yong Kim, et al. · Journal of Clinical Oncology · 16
Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer
2011 · Han Jo Kim, Kyoung Ha Kim, et al. · Cancer Research and Treatment · 15
PDF
Epigenetic inactivation of RUNX3 in colorectal cancer
2018 · Eung Jin Shin, Han Jo Kim, et al. · Annals of Surgical Treatment and Research · 14
PDF
Low-dose combinations of LBH589 and TRAIL can overcome TRAIL-resistance in colon cancer cell lines.
2011 · Sang-Cheol Lee, Hee-Jeong Cheong, et al. · PubMed · 14
Expression of AMP‑activated protein kinase/ten‑eleven translocation 2 and their clinical relevance in colorectal cancer
2021 · Dong Hyun Kang, Dong Jun Jeong, et al. · Oncology Letters · 12
PDF
The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancer
2018 · Seug Yun Yoon, Min-Young Lee, et al. · Blood Research · 12
PDF
Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: Angiogenic markers of neoadjuvant chemoradiation
2014 · HAN JO KIM, SANG BYUNG BAE, et al. · Oncology Reports · 12
PDF
Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial
2021 · Sung Hee Lim, Jina Yun, et al. · Yonsei Medical Journal · 11
Works count: 73
Citation count: 948
H-index: 17
I10-index: 29
Year
Topic
Type